Preparation and characterization of electrospun fibrous scaffolds of either PVA or PVP for fast release of sildenafil citrate

Sildenafil citrate (SC) has proved to be an effective and inexpensive drug for the treatment of pulmonary arterial hypertension (PAH). This study aims to synthesize electrospun, submicron fiber scaffolds of poly(vinyl alcohol) (PVA) and poly(vinyl pyrrolidone) (PVP) loaded with SC for fast drug diss...

Full description

Saved in:
Bibliographic Details
Published ine-Polymers Vol. 20; no. 1; pp. 746 - 758
Main Authors Torres-Martínez, Erick José, Vera-Graziano, Ricardo, Cervantes-Uc, José Manuel, Bogdanchikova, Nina, Olivas-Sarabia, Amelia, Valdez-Castro, Ricardo, Serrano-Medina, Aracely, Iglesias, Ana Leticia, Pérez-González, Graciela Lizeth, Cornejo-Bravo, José Manuel, Villarreal-Gómez, Luis Jesús
Format Journal Article
LanguageEnglish
Published Berlin De Gruyter 01.01.2020
Walter de Gruyter GmbH
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Sildenafil citrate (SC) has proved to be an effective and inexpensive drug for the treatment of pulmonary arterial hypertension (PAH). This study aims to synthesize electrospun, submicron fiber scaffolds of poly(vinyl alcohol) (PVA) and poly(vinyl pyrrolidone) (PVP) loaded with SC for fast drug dissolution and its potential use in the treatment of PAH. These fiber scaffolds were prepared through the electrospinning technique. The chemical composition of the nanofibers was analyzed by Fourier transform infrared spectroscopy. Thermal stability was studied by thermogravimetric analysis and polymeric transitions by differential scattering calorimetry. Surface analysis of the nanofibers was studied by field emission scanning electron microscopy. The wetting and dissolution time of the scaffolds and drug release rate were studied as well. The drug-loaded PVP fibers showed better quality regarding size and homogeneity compared to drug-loaded PVA fibers. These fibers encapsulated approximately 2.5 mg/cm of the drug and achieved immediate controlled released rate, which is encouraging for further studies leading to an alternative treatment of PAH in children.
ISSN:2197-4586
1618-7229
DOI:10.1515/epoly-2020-0070